Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Utah Medical Products	The Westaim	DarioHealth	Cytosorbents	Apyx Medical
Symbol	NASDAQ:UTMD	OTCMKTS:WEDXF	NASDAQ:DRIO	NASDAQ:CTSO	NASDAQ:APYX
Price Information
Current Price	$86.24	$2.04	$15.37	$7.44	$9.48
50-Day Moving Average	$85.38	$2.18	$18.90	$7.97	$9.99
52-Week Low	$77.22	$1.46	$7.00	$7.13	$4.35
52-Week High	$95.64	$2.36	$31.85	$11.68	$12.01
MarketRank™
Overall Score	0.8	1.4	1.5	1.7	1.5
Analysis Score	0.0	3.5	3.4	3.5	3.5
Community Score	2.1	2.7	2.6	3.5	2.6
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.0	0.8	0.8	0.8
Earnings & Valuation Score	0.0	0.6	0.6	0.6	0.6
Analyst Ratings
Consensus Recommendation	N/A	Buy	Buy	Buy	Buy
Consensus Price Target	N/A	$4.15	$26.38	$15.67	$13.00
% Upside from Price Target	N/A	103.26% upside	71.60% upside	110.57% upside	37.13% upside
Trade Information
Market Cap	$314.78 million	$292.35 million	$238.85 million	$322.30 million	$325.35 million
Beta	0.25	0.71	1.34	0.28	0.75
Average Volume	11,294	52,803	283,884	311,805	129,888
Sales & Book Value
Annual Revenue	$42.18 million	$24.85 million	$7.58 million	$41.01 million	$27.71 million
Price / Sales	7.46	11.76	31.51	7.86	11.74
Cashflow	$5.01 per share	$0.04 per share	N/A	N/A	N/A
Price / Cash	17.21	57.23	N/A	N/A	N/A
Book Value	$28.25 per share	$2.24 per share	$3.47 per share	$1.83 per share	$1.86 per share
Price / Book	3.05	0.91	4.43	4.07	5.10
Profitability
Net Income	$10.80 million	$-34,400,000.00	$-29,440,000.00	$-7,840,000.00	$-11,900,000.00
EPS	N/A	N/A	($4.01)	($0.20)	($0.57)
Trailing P/E Ratio	29.53	N/A	N/A	N/A	N/A
Forward P/E Ratio	∞	∞	N/A	82.67	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	25.29%	-219.20%	-370.22%	-19.94%	-47.35%
Return on Equity (ROE)	10.65%	4.40%	-74.88%	-13.11%	-24.39%
Return on Assets (ROA)	9.78%	3.78%	-64.48%	-10.34%	-20.86%
Dividend
Annual Payout	$1.14	N/A	N/A	N/A	N/A
Dividend Yield	1.32%	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	5.63%	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	1 Years	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.12%	N/A	N/A	N/A
Current Ratio	14.59%	0.63%	7.52%	8.16%	6.48%
Quick Ratio	13.28%	0.63%	7.09%	7.84%	6.02%
Ownership Information
Institutional Ownership Percentage	72.29%	0.01%	35.18%	40.03%	55.27%
Insider Ownership Percentage	7.00%	4.21%	21.20%	5.70%	10.00%
Miscellaneous
Employees	181	7	127	195	266
Shares Outstanding	3.65 million	143.19 million	15.54 million	43.32 million	34.32 million
Next Earnings Date	10/26/2021 (Estimated)	8/12/2021 (Estimated)	8/11/2021 (Estimated)	8/3/2021 (Confirmed)	8/12/2021 (Confirmed)
Optionable	Not Optionable	Not Optionable	Not Optionable	Optionable	Optionable

Source	Headline
	Comparing Apyx Medical (NASDAQ:APYX) & Axonics (NASDAQ:AXNX) americanbankingnews.com - July 20 at 1:14 AM
	We're Hopeful That Apyx Medical (NASDAQ:APYX) Will Use Its Cash Wisely finance.yahoo.com - July 14 at 6:28 AM
	Apyx Medical Corporation to Release Second Quarter… pharmiweb.com - July 12 at 7:35 PM
	Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021 finance.yahoo.com - July 12 at 4:53 PM
	Apyx Medical (NASDAQ:APYX) Earns "Buy" Rating from Colliers Securities americanbankingnews.com - June 28 at 8:58 AM
	Apyx Medical Corporation (APYX) finance.yahoo.com - June 18 at 12:09 AM
	Paratek Appoints Minnie Baylor-Henry to Company’s Board of Directors in.finance.yahoo.com - June 14 at 8:57 AM
	Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion ® in Dermal Resurfacing Procedures businesswire.com - June 1 at 9:49 AM
	Is Apyx Medical Corporation (NASDAQ:APYX) Popular Amongst Insiders? nasdaq.com - June 1 at 8:11 AM
	Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures finance.yahoo.com - June 1 at 8:11 AM
	ROCE Insights For Apyx Medical benzinga.com - May 26 at 1:32 PM
	Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates finance.yahoo.com - May 12 at 1:17 PM
	BRIEF-Apyx Medical Corp. Reports Q1 Revenue Of $8.6 Mln msn.com - May 12 at 8:15 AM
	Apyx: Q1 Earnings Snapshot \| Raleigh News & Observer newsobserver.com - May 12 at 8:15 AM
	Apyx: Q1 Earnings Snapshot greenwichtime.com - May 12 at 8:15 AM
	Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook finance.yahoo.com - May 12 at 8:15 AM
	Could The Apyx Medical Corporation (NASDAQ:APYX) Ownership Structure Tell Us Something Useful? finance.yahoo.com - May 11 at 8:51 AM
	Cold Plasma Market SWOT Analysis by Key Players: Tantec, Europlasma, Thierry sbwire.com - April 30 at 12:46 PM
	Apyx Medical Corporation to Release First Quarter… pharmiweb.com - April 12 at 8:00 PM
	Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021 finance.yahoo.com - April 12 at 8:00 PM
	Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q4 2020 Results - Earnings Call Transcript seekingalpha.com - April 2 at 10:32 AM
	Apyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Lifting Their Price Targets nasdaq.com - April 2 at 9:27 AM
	Apyx Medical: Q4 Earnings Insights benzinga.com - March 31 at 10:48 AM
	BRIEF-Apyx Medical Sees FY 2021 Revenue $36.7 Mln To $38.7 Mln msn.com - March 31 at 10:48 AM
	Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates finance.yahoo.com - March 31 at 10:48 AM

Date	Company	Brokerage	Action
6/28/2021	Apyx Medical	Colliers Securities	Reiterated Rating
5/24/2021	DarioHealth	Alliance Global Partners	Lower Price Target
5/18/2021	DarioHealth	Stifel Nicolaus	Lower Price Target
4/22/2021	DarioHealth	Cowen	Initiated Coverage
3/30/2021	Apyx Medical	Colliers Securities	Reiterated Rating
3/22/2021	DarioHealth	Stifel Nicolaus	Initiated Coverage
2/25/2021	DarioHealth	Cantor Fitzgerald	Initiated Coverage
2/8/2021	DarioHealth	Aegis	Boost Price Target
2/1/2021	DarioHealth	Alliance Global Partners	Downgrade
1/29/2021	Apyx Medical	Piper Sandler	Boost Price Target
1/7/2021	The Westaim	Stifel Nicolaus	Boost Price Target
1/4/2021	Cytosorbents	B. Riley	Boost Price Target
9/17/2020	Cytosorbents	Jefferies Financial Group	Initiated Coverage
9/1/2020	Cytosorbents	SVB Leerink	Initiated Coverage
8/17/2020	DarioHealth	Aegis	Initiated Coverage
8/13/2020	DarioHealth	Craig Hallum	Boost Price Target
7/23/2020	Cytosorbents	B. Riley	Reiterated Rating
6/22/2020	DarioHealth	ThinkEquity	Initiated Coverage
6/12/2020	Cytosorbents	B. Riley	Initiated Coverage
5/13/2020	DarioHealth	Craig Hallum	Boost Price Target
5/12/2020	Apyx Medical	JMP Securities	Lower Price Target
5/7/2020	Cytosorbents	Maxim Group	Initiated Coverage
5/6/2020	Cytosorbents	HC Wainwright	Boost Price Target
5/6/2020	Cytosorbents	B. Riley	Boost Price Target
4/16/2020	Cytosorbents	HC Wainwright	Reiterated Rating
3/26/2020	Cytosorbents	Maxim Group	Reiterated Rating
3/18/2020	DarioHealth	Craig Hallum	Lower Price Target
3/17/2020	Apyx Medical	Piper Sandler	Lower Price Target
3/9/2020	Cytosorbents	Dawson James	Reiterated Rating
3/6/2020	Cytosorbents	HC Wainwright	Reiterated Rating
12/4/2019	DarioHealth	Craig Hallum	Lower Price Target
11/27/2019	Cytosorbents	B. Riley	Reiterated Rating
11/26/2019	Cytosorbents	HC Wainwright	Reiterated Rating
11/25/2019	Cytosorbents	Maxim Group	Reiterated Rating
11/11/2019	Apyx Medical	Piper Jaffray Companies	Boost Price Target
10/21/2019	Cytosorbents	B. Riley	Set Price Target
8/7/2019	Cytosorbents	HC Wainwright	Reiterated Rating
8/7/2019	Cytosorbents	Maxim Group	Set Price Target
7/19/2019	Cytosorbents	B. Riley	Set Price Target
6/6/2019	DarioHealth	Craig Hallum	Initiated Coverage
5/8/2019	Cytosorbents	Maxim Group	Set Price Target
5/8/2019	Apyx Medical	Piper Jaffray Companies	Lower Price Target
4/2/2019	Apyx Medical	Dougherty & Co	Lower Price Target
4/2/2019	Apyx Medical	JMP Securities	Lower Price Target
3/8/2019	Cytosorbents	Maxim Group	Reiterated Rating
3/8/2019	Cytosorbents	HC Wainwright	Reiterated Rating
2/11/2019	Apyx Medical	Piper Jaffray Companies	Boost Price Target
1/14/2019	Cytosorbents	HC Wainwright	Set Price Target
12/20/2018	Cytosorbents	Maxim Group	Set Price Target
11/7/2018	Cytosorbents	HC Wainwright	Set Price Target
9/14/2018	Apyx Medical	Dougherty & Co	Reiterated Rating

(Data available from 7/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources